Julius Ulrich, Frind Antje, Tselmin Sergej, Kopprasch Steffi, Poberschin Ines, Siegert Gabriele
University Hospital Dresden, Medical Clinic III, Fetscherstr. 74, 01307 Dresden, Germany.
Expert Rev Cardiovasc Ther. 2008 Jun;6(5):629-39. doi: 10.1586/14779072.6.5.629.
This article presents the generally accepted indications for LDL apheresis treatment. The available LDL apheresis methods differ with respect to acute relative reductions of LDL cholesterol; mean values after the LDL apheresis treatments are not different. Serum triglycerides, HDL-cholesterol, and lipoprotein(a) are also acutely reduced. Available LDL apheresis methods differ with respect to their impact on the coagulation system, on C-reactive protein and on leukocyte count. Cardiovascular events are clearly reduced by the LDL apheresis methods. There is an urgent need to prospectively compare the different LDL apheresis methods taking into account hard end points. The lower target values for LDL cholesterol suggested by international guidelines for high-risk patients will certainly require a more widespread use of LDL apheresis.
本文介绍了低密度脂蛋白单采治疗的普遍公认适应症。现有的低密度脂蛋白单采方法在低密度脂蛋白胆固醇的急性相对降低方面存在差异;低密度脂蛋白单采治疗后的平均值并无差异。血清甘油三酯、高密度脂蛋白胆固醇和脂蛋白(a)也会急性降低。现有的低密度脂蛋白单采方法在对凝血系统、C反应蛋白和白细胞计数的影响方面存在差异。低密度脂蛋白单采方法可明显减少心血管事件。迫切需要前瞻性地比较不同的低密度脂蛋白单采方法,并考虑到硬性终点。国际高危患者指南建议的更低的低密度脂蛋白胆固醇目标值肯定会要求更广泛地使用低密度脂蛋白单采。